Ebanga approved to treat Ebola in adult and paediatric patients More: Ridgeback Biotherapeutics’ Ebola treatment scores FDA approval Source: News
read moreSubmission supported by results from phase II CodeBreaK 100 study More: Amgen files KRAS inhibitor sotorasib with EMA Source: News
read moreREACH-CDM study was based on results of positive phase II data More: AMO Pharma launches late-stage study of CMD candidate Source: News
read moreThe inside story behind Pfizer and BioNTech’s new vaccine brand name, Comirnaty bbulik Wed, 12/23/2020 – 09:26 More: The inside story behind Pfizer and BioNTech's new vaccine brand name, Comirnaty Source: fierce
read moreTakeda offloads heart and metabolism drugs to 3-month-old Chinese firm for $322M aliu Wed, 12/23/2020 – 08:53 More: Takeda offloads heart and metabolism drugs to 3-month-old Chinese firm for 2M Source: fierce
read morePfizer, feds ink another COVID-19 vaccine supply deal for 100M doses esagonowsky Wed, 12/23/2020 – 08:29 More: Pfizer, feds ink another COVID-19 vaccine supply deal for 100M doses Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals